We isolated CD44+CD24− CSC from 26 triple-negative breast cancer tissues to generate Nestin-overexpressing (Nestin+), Nestin-silencing (Nestin-si), and control (Nestin-c) CSC. Here, CD44 is linked to triple-negative breast carcinoma.